Cargando…
Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib
BACKGROUND: Type I interferonopathies are a group of rare autoimmune diseases characterised by excessive activation of type I interferon that leads to disturbances in immune function. Three prime repair exonuclease 1 (TREX1) is an important exonuclease and plays an important role in DNA damage repai...
Autores principales: | Zhang, Shiyu, Song, Jiaxing, Yang, Yuyan, Miao, Huilei, Yang, Lu, Liu, Yuehua, Zhang, Xue, Liu, Yaping, Wang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789551/ https://www.ncbi.nlm.nih.gov/pubmed/33407657 http://dx.doi.org/10.1186/s12969-020-00490-1 |
Ejemplares similares
-
Suppression of TREX1 deficiency-induced cellular senescence and interferonopathies by inhibition of DNA damage response
por: Du, Hekang, et al.
Publicado: (2023) -
Myasthenia Gravis: An Acquired Interferonopathy?
por: Payet, Cloé A., et al.
Publicado: (2022) -
Lung involvement in monogenic interferonopathies
por: Cazzato, Salvatore, et al.
Publicado: (2020) -
Type I Interferonopathies in Childhood
por: Haşlak, Fatih, et al.
Publicado: (2023) -
Compound heterozygous GLI3 variants in siblings with thyroid hemiagenesis
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2020)